Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ORMP held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BML Capital Management, LLC | 3.2M | $10.8M | 0.0% | 7.739% | 6.93% |
| 2 | Aquamarine Financial (Cayman) Ltd | 2.1M | $7.2M | +7.1% | 5.161% | 0.53% |
| 3 | MERCER GLOBAL ADVISORS INC /ADV | 1.9M | $6.5M | β | 4.668% | 0.01% |
| 4 | Gem Investment Advisors, LLC | 1.6M | $5.6M | β | 4.007% | 2.69% |
| 5 | Murchinson Ltd. | 1.3M | $4.5M | -1.9% | 3.214% | 1.27% |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | 601K | $2.0M | -1.9% | 1.468% | 0.05% |
| 7 | MARSHALL WACE, LLP | 260K | $883K | +0.2% | 0.634% | 0.00% |
| 8 | Rathbone Brothers plc | 233K | $792K | 0.0% | 0.569% | 0.00% |
| 9 | DIMENSIONAL FUND ADVISORS LP | 158K | $538K | +5.1% | 0.387% | 0.00% |
| 10 | WELLS FARGO & COMPANY/MN | 158K | $536K | +20.7% | 0.385% | 0.00% |
| 11 | RITHOLTZ WEALTH MANAGEMENT | 155K | $529K | β | 0.380% | 0.01% |
| 12 | RENAISSANCE TECHNOLOGIES LLC | 148K | $502K | +0.1% | 0.361% | 0.00% |
| 13 | BANK OF AMERICA CORP /DE/ | 146K | $497K | +2.8% | 0.357% | 0.00% |
| 14 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 136K | $463K | +424.2% | 0.333% | 0.00% |
| 15 | O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 116K | $396K | β | 0.284% | 0.00% |
| 16 | CITADEL ADVISORS LLC | 99K | $335K | -49.7% | 0.241% | 0.00% |
| 17 | Hillsdale Investment Management Inc. | 97K | $331K | β | 0.238% | 0.01% |
| 18 | BlackRock, Inc. | 92K | $313K | +2.2% | 0.225% | 0.00% |
| 19 | JANE STREET GROUP, LLC | 53K | $179K | -32.9% | 0.128% | 0.00% |
| 20 | Hudson Bay Capital Management LP | 52K | $176K | β | 0.126% | 0.00% |
| 21 | Connor, Clark & Lunn Investment Management Ltd. | 50K | $171K | +14.8% | 0.123% | 0.00% |
| 22 | PRELUDE CAPITAL MANAGEMENT, LLC | 35K | $120K | +63.4% | 0.086% | 0.01% |
| 23 | BAILARD, INC. | 32K | $110K | β | 0.079% | 0.00% |
| 24 | AMERICAN CENTURY COMPANIES INC | 32K | $110K | +64.9% | 0.079% | 0.00% |
| 25 | Point72 Asset Management, L.P. | 26K | $89K | +2.4% | 0.064% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in ORMP β a direct measure of their conviction.
Filings activity in ORMP during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 63 | +17% | 28.25% | +8.37 pp | $45M | +42% |
| Q4 2025 | 54 | +23% | 19.88% | +7.84 pp | $31M | +65% |
| Q3 2025 | 44 | 8.3% | 12.04% | +1.71 pp | $19M | +17% |
| Q2 2025 | 48 | 7.7% | 10.33% | 0.10 pp | $16M | 1.0% |
| Q1 2025 | 52 | 5.5% | 10.43% | 1.77 pp | $17M | 14% |
| Q4 2024 | 55 | +3.8% | 12.20% | +1.57 pp | $19M | +15% |
| Q3 2024 | 53 | 10% | 10.63% | +2.40 pp | $17M | +29% |
| Q2 2024 | 59 | β | 8.23% | β | $13M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ORMP stock.
Based on Q1 2026 13F filings, institutional ownership of Oramed Pharmaceuticals Inc. stands at 28.2%, held across 63 reporting institutions.
BML Capital Management, LLC is the largest reported institutional holder of ORMP, with approximately 3,167,231 shares worth $0.01B as of Q1 2026.
Yes β 5 widely-followed marquee investors appear among the top 25 institutional holders of ORMP, including RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC, Point72 Asset Management, L.P..
Our composite Smart Money Score for ORMP is 82 out of 100 (Strong Smart Money). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
19 institutions opened new positions in ORMP during Q1 2026, while 10 fully exited. 34 added to existing positions and 10 trimmed.
ORMP institutional ownership rose by 8.37 percentage points quarter-over-quarter, with a net change of +9 holders.
The top 10 institutions account for 87.8% of all reported 13F value in ORMP, and the top 25 account for 97.4%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Oramed Pharmaceuticals Inc. (ORMP) Institutional Ownership